News & Events
Patients with secondary progressive MS who have ongoing relapses may benefit from continuing immunomodulatory therapies after onset…
Over 35 per cent of patients with clinically isolated syndrome were diagnosed earlier when applying the 2010…
The results suggest that primary progressive and relapsing forms of MS have different underlying mechanisms
Switching patients with relapsing-remitting MS from interferon to glatiramer acetateis associated with positive treatment outcomes
MS International Federation calls on the UN to ensure new global goals benefit all - including people…
The theme for 2015 will be access, and the campaign will celebrate breaking down barriers to living…
The Alliance has been joined by four MS International Federation member organisations
The MS International Federation encourages everyone affected by MS to sign the declaration
Underweight women and patients with low baseline lymphocyte counts should be monitored more closely
A new way to predict the transition from relapsing-remitting to secondary-progressive MS
Computer-aided cognitive rehabilitation can slow down cognitive impairment in MS patients
French study supports the idea of avoiding delays after pregnancy before starting natalizumab therapy